Lipocine 8-K/A adds Michael Grissinger to compensation committee
LPCN•Amended filing updates Grissinger appointment
- Lipocine filed an amended Form 8-K to update its earlier report on director Michael Grissinger’s appointment.
- The amendment adds that the board named Grissinger to its Compensation Committee on Aug. 18, 2026.
- Compensation Committee service makes Grissinger eligible for an additional $7,500 per year.
